Vuk-Pavlovic S - Search Results

1

Vuk-Pavlovic S. Vuk-Pavlovic S. Blood Cells Mol Dis. 2008 Jan-Feb;40(1):94-100. doi: 10.1016/j.bcmd.2007.06.025. Epub 2007 Sep 10. Blood Cells Mol Dis. 2008. PMID: 17827037 Free PMC article. Review.

2

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Vuk-Pavlović S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB. Vuk-Pavlović S, et al. Prostate. 2010 Mar 1;70(4):443-55. doi: 10.1002/pros.21078. Prostate. 2010. PMID: 19902470 Free PMC article.

3

Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T-cell clustering.

Fisher PJ, Bulur PA, Vuk-Pavlovic S, Prendergast FG, Dietz AB. Fisher PJ, et al. Blood. 2008 Dec 15;112(13):5037-45. doi: 10.1182/blood-2008-04-149526. Epub 2008 Sep 19. Blood. 2008. PMID: 18805966 Free article.

4

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlović S. Burch PA, et al. Clin Cancer Res. 2000 Jun;6(6):2175-82. Clin Cancer Res. 2000. PMID: 10873066 Clinical Trial.

5

Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo.

Dietz AB, Souan L, Knutson GJ, Bulur PA, Litzow MR, Vuk-Pavlovic S. Dietz AB, et al. Blood. 2004 Aug 15;104(4):1094-9. doi: 10.1182/blood-2003-12-4266. Epub 2004 Apr 20. Blood. 2004. PMID: 15100154 Free article.

6

Effects of oxygen on the antigenic landscape of prostate cancer cells.

Ma T, Schreiber CA, Knutson GJ, Khattouti AE, Sakiyama MJ, Hassan M, Charlesworth MC, Madden BJ, Zhou X, Vuk-Pavlović S, Gomez CR. Ma T, et al. Among authors: vuk pavlovic s. BMC Res Notes. 2015 Nov 18;8:687. doi: 10.1186/s13104-015-1633-7. BMC Res Notes. 2015. PMID: 26581192 Free PMC article.

7

Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.

Burch PA, Croghan GA, Gastineau DA, Jones LA, Kaur JS, Kylstra JW, Richardson RL, Valone FH, Vuk-Pavlović S. Burch PA, et al. Prostate. 2004 Aug 1;60(3):197-204. doi: 10.1002/pros.20040. Prostate. 2004. PMID: 15176049 Clinical Trial.

8

High efficiency adenovirus-mediated gene transfer to human dendritic cells.

Dietz AB, Vuk-Pavlović S. Dietz AB, et al. Blood. 1998 Jan 15;91(2):392-8. Blood. 1998. PMID: 9427691 Free article.

9

Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia.

Dietz AB, Litzow MR, Gastineau DA, Vuk-Pavlović S. Dietz AB, et al. Croat Med J. 2001 Aug;42(4):428-35. Croat Med J. 2001. PMID: 11471194 Free article. Review.

10

Immune cells in the human choroid.

Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Ezzat MK, et al. Br J Ophthalmol. 2008 Jul;92(7):976-80. doi: 10.1136/bjo.2007.129742. Br J Ophthalmol. 2008. PMID: 18577650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters